Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Time to Buy?

Telix Pharmaceuticals Limited American Depositary Shares logo with Medical background

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s stock price gapped up prior to trading on Friday . The stock had previously closed at $16.43, but opened at $16.81. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.50, with a volume of 1,786 shares.

Analyst Ratings Changes

Separately, William Blair reaffirmed an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research report on Wednesday, March 12th.

Check Out Our Latest Research Report on TLX

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The stock's 50 day moving average price is $16.78 and its 200-day moving average price is $16.79.

Hedge Funds Weigh In On Telix Pharmaceuticals Limited American Depositary Shares

An institutional investor recently bought a new position in Telix Pharmaceuticals Limited American Depositary Shares stock. ABC Arbitrage SA bought a new position in Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 26,939 shares of the company's stock, valued at approximately $451,000.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.

Further Reading

Should You Invest $1,000 in Telix Pharmaceuticals Limited American Depositary Shares Right Now?

Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.

While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines